CIM 3.33 Chimera Investment Corp $CIM Hit a 52 week high of

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
CIM 3.33 Chimera Investment Corp $CIM Hit a 52 week high of 3.35 Closing the day 09:44 at 3.33 -0.02 -0.60% With a day low of 3.33 and a total volume of 130,660.

CIM Recent Posts: http://investorshangout.com/Chimera-Investmen...CIM-50528/

CIM Chimera Investment Corp Recent Headline News

5 Russell 1000 Dogs Seize 15.7% To 43.4% November Upsides
Fredrik Arnold - at Seeking Alpha - Mon Nov 17, 2:38PM CST

AGNC: 23.02 (-0.10), CLF: 8.30 (+0.13), RRD: 16.67 (+0.07), SDRL: 21.14 (+0.45), WIN: 9.85 (+0.02), STWD: 23.37 (-0.16), SLM: 9.70 (-0.15), IMS: 25.51 (-0.01), MFA: 8.22 (unch), CIM: 3.33 (-0.02), CXW: 35.37 (-0.04), TWO: 10.32 (unch), OHI: 36.96 (-0.04), SIX: 39.75 (-0.37), ARCP: 8.99 (+0.22), NRF: 17.92 (-0.02)

Why Investors Should Consider Chimera Investment Corporation's Huge 11% Dividend Yield
Kingkarn Amjaroen, The Motley Fool - Motley Fool - Sat Nov 15, 7:43AM CST
Chimera Investment   offer investors more than a high dividend yield: The mortgage real estate investment trust in 2014 reversed its trend of  falling book value , has a comparatively stable dividend, and reported strong third-quarter numbers in...
NLY: 11.44 (-0.03), CIM: 3.33 (-0.02), AGNC: 23.02 (-0.10)

Chimera Is One Hell Of An mREIT This Year
Christopher F. Davis - at Seeking Alpha - Wed Nov 12, 2:15PM CST

CIM: 3.33 (-0.02)

Chimera Investment's (CIM) CEO Matt Lambiase on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 12, 1:38PM CST

CIM: 3.33 (-0.02)

13 Stocks With Dividend Yields Over 10%
Dividend Yield - at Seeking Alpha - Wed Nov 12, 9:28AM CST
I know you like dividends and can't wait to receive the next payment from your favorite company. Dividends are great, but most of the dividend stocks don't give you high amounts of cash into your pocket. Why don't we look for stocks with very high...
DCT: 33.39 (-0.02), NLY: 11.44 (-0.03), LNCO: 20.98 (+0.50), CIM: 3.33 (-0.02), TWO: 10.32 (unch), AGNC: 23.02 (-0.10), BBEP: 15.20 (+0.47), NTI: 24.97 (+0.12), ARCP: 8.99 (+0.22), LINE: 22.92 (+0.31), WIN: 9.85 (+0.02), PSEC: 9.65 (unch), VNR: 25.28 (+0.41)

After Yesterday's Rally of 2.54% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Nov 11, 4:54PM CST
Chimera Investment (AMEX:CIM) traded in a range yesterday that spanned from a low of $3.16 to a high of $3.24. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $3.16 on volume of 11.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CIM: 3.33 (-0.02)

Look for Shares of Chimera Investment to Potentially Pullback after Yesterday's 2.54% Rise
Comtex SmarTrend(R) - Tue Nov 11, 4:53PM CST
Chimera Investment (AMEX:CIM) traded in a range yesterday that spanned from a low of $3.16 to a high of $3.24. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $3.16 on volume of 11.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CIM: 3.33 (-0.02)

Chimera Investment (CIM) Stock Climbs Today Following Earnings Beat
at The Street - Tue Nov 11, 10:46AM CST
Chimera Investment (CIM) shares are up after the company beat analysts earnings expectations for the third quarter.
CIM: 3.33 (-0.02)

CORRECTING and REPLACING Chimera Investment Corporation Reports EPS for the 3rd Quarter 2014 of $0.37 Per Share, Core Earnings of $0.11 Per Share and Book Value of $3.50 Per Share
Business Wire - Mon Nov 10, 4:16PM CST
Headline of release should read: Chimera Investment Corporation Reports EPS for the 3rd Quarter 2014 of $0.37 Per Share, Core Earnings of $0.11 Per Share and Book Value of $3.50 Per Share (Instead of Core Earnings of $0.12 Per Share)
CIM: 3.33 (-0.02)

Chimera core income book value gain
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 3:51PM CST

CIM: 3.33 (-0.02)

Chimera Investment beats by $0.02
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 3:42PM CST

CIM: 3.33 (-0.02)

Chimera Investment Corporation Reports EPS for the 3rd Quarter 2014 of $0.37 Per Share, Core Earnings of $0.12 Per Share and Book Value of $3.50 Per Share
Business Wire - Mon Nov 10, 3:35PM CST
Chimera Investment Corporation (NYSE:CIM) today announced its financial results for the quarter ended September 30, 2014.
CIM: 3.33 (-0.02)

Technical Coverage on Mortgage REITs Stocks - Newcastle Investment, Chimera Investment, Annaly Capital Management, Invesco Mortgage Capital, and MFA Financial
PR Newswire - Tue Nov 04, 7:40AM CST
Investor-Edge has initiated coverage on the following equities: Newcastle Investment Corporation (NYSE: NCT), Chimera Investment Corporation (NYSE: CIM), Annaly Capital Management Inc. (NYSE: NLY), Invesco Mortgage Capital Inc. (NYSE: IVR), and MFA Financial Inc. (NYSE: MFA). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Monday, November 03, 2014, the NASDAQ Composite ended at 4,638.91, up 0.18%, the Dow Jones Industrial Average edged 0.14% lower to finish the day at 17,366.24, and the S&P 500 closed at 2,017.81, down 0.01%. The gains were broad based as seven out of ten sectors ended the session in positive. The S&P 500 Financials Sector Index ended the day at 322.21, up 0.31%, and the index has advanced 7.69% in the previous three months. Register for your complimentary reports on these five stocks at:
IVR: 16.18 (unch), NLY: 11.44 (-0.03), MFA: 8.22 (unch), CIM: 3.33 (-0.02), NCT: 4.81 (+0.01)

Chimera Investment Corporation Announces Date of Third Quarter 2014 Conference Call
Business Wire - Thu Oct 30, 4:31PM CDT
Chimera Investment Corporation. (NYSE:CIM) (the "Company" announced today that it will release its financial results for the quarter ended September 30, 2014 after the market close on Monday, November 10, 2014 and will conduct a conference call and audio webcast to discuss the results on Wednesday, November 12, 2014 at 10:00 a.m. EDT.
CIM: 3.33 (-0.02)

Homeownership Programs, New Apps for Mortgage and Real Estate Professionals, Dividend, and Market Activity - Research Reports on Radian, Banco Santander, BioMed Realty, Chimera and Genworth
PR Newswire - Fri Oct 17, 7:35AM CDT
Today, Analysts Review released its research reports regarding Radian Group Inc. (NYSE: RDN), Banco Santander, S.A. (NYSE: SAN), BioMed Realty Trust Inc. (NYSE: BMR), Chimera Investment Corporation (NYSE: CIM) and Genworth Financial, Inc. (NYSE: GNW). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7255-100free.
SAN: 8.29 (-0.16), BMR: 20.83 (-0.13), RDN: 16.90 (+0.17), CIM: 3.33 (-0.02), GNW: 9.23 (+0.10)

Chimera Investment Corporation: Very Impressive
Christopher F. Davis - at Seeking Alpha - Thu Oct 16, 7:24PM CDT

NLY: 11.44 (-0.03), CIM: 3.33 (-0.02), AGNC: 23.02 (-0.10)

Cheap Stocks Wall Street Hates: Chimera Investment Corporation
Sean Williams, The Motley Fool - Motley Fool - Mon Oct 13, 7:30AM CDT
If timing really was everything, then Chimera Investment would be graded an "F" for going public in Nov. 2007, right as the stock market was having the rug pulled out right from underneath it. Although Chimera investors have been in for a...
CIM: 3.33 (-0.02)

Cheaper Dividend Stock: Two Harbors Investment Corp. or Chimera Investment?
Dave Koppenheffer, The Motley Fool - Motley Fool - Sun Oct 12, 6:05PM CDT
Leave your price-to-earnings ratio and PEG ratio behind because today we're talking mortgage REITs Chimera Investment   and Two Harbors Investment Corp . , and to evaluate these high-yielding stocks we'll need a new bag of tricks. By digging into...
CIM: 3.33 (-0.02), TWO: 10.32 (unch)

Market Maker Surveillance Report. NLY, CIM, GSAT, ITUB, LNEGY, MONIF, Highest Net Buy Volume With Lowest Price Friction For Tuesday, October 7th 2014
M2 - Wed Oct 08, 4:25AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4746 companies with "abnormal" market making, 1204 companies with positive Friction Factors and 3932 companies with negative Friction Factors. Here is a list of the top companies with the highest net buy volume on Tuesday and lowest price Friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Annaly Capital Management Inc (NYSE:NLY), Chimera Investment Corp (NYSE:CIM), Globalstar Inc (OTC:GSAT), Itau Unibanco Holding SA (NYSE:ITUB), Linde AG (OTC:LNEGY), MONITISE PLC (OTC:MONIF). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
NLY: 11.44 (-0.03), CIM: 3.33 (-0.02), ITUB: 15.17 (+0.46), GSAT: 2.65 (-0.02)

Better Dividend Stock: American Capital Agency Corp. vs Chimera Investment Corporation
Dave Koppenheffer, The Motley Fool - Motley Fool - Wed Sep 24, 2:01PM CDT
American Capital Agency   is a better dividend stock than Chimera Investment  , and I'm going to tell you why. Chimera is exposed to credit risk -- risk that its assets will default -- and American Capital Agency has...
CIM: 3.33 (-0.02), AGNC: 23.02 (-0.10)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nonprofit and Partners Gift Homes to Veterans

Updated Category News Views 100

A Heartfelt Gesture on Veterans Day Now this is the kind of story that gets you right in the gut. On November 9, two veterans, who were likely walking into a golf club thinking it was just another evening, were handed the keys to a future they might have only dreamt of: a mortgage-free home. Operation Finally Home, backed by the big names like Lennar and the patriotic...

Continue Reading
Surprising Week on Wall Street: Chips Drive Gains

Updated Category News Views 141

A Wild Week in Wall Street Well, folks, what a week it’s been on Wall Street. The indexes danced the cha-cha, making gains despite closing Friday on a lower note. Despite the retreat, we've got ourselves a week where the major indexes closed higher than the previous Friday. It's not the usual story, but who ever thought stocks played by the rules? The Nasdaq Composite...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 141

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 83

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
LA Fitness ELEVATE Opens at RITHM: A New Era Dawns

Updated Category News Views 66

Elevating Fitness at RITHM: A New Era Has Begun RD Management just dropped a new ace in Tampa Bay’s hand—LA Fitness ELEVATE at the RITHM at Uptown. They lit up the scene with this 30,000-square-foot beast of a gym, and I’ll tell you, it’s not your standard run-of-the-mill joint. When you toss twelve-and-a-half million bucks into a pot, you're aiming to lure folks...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 99

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 155

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Gemmy's Holiday Lights: Bright Ideas for 2026

Updated Category News Views 149

Deep in the heart of Dallas, Gemmy Industries is out to sprinkle a bit of magic over the holiday season for 2026. This ain't your grandma's string lights we're talkin' about here. We're diving headfirst into a new world of seasonal decor with tech-driven lights that look like they came straight outta a winter wonderland. And hey, if Walmart's set to host this lineup, you...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 177

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading

Top 5 Most Recently Viewed Articles

NexPoint Capital Launches Tender Offer for Shareholders

Updated Category News Views 217

NexPoint Capital Begins Tender Offer for Its Common Stock NexPoint Capital, Inc. (the "Company"), a publicly registered business development company expertly managed by NexPoint Advisors, L.P., is set to kick off a voluntary tender offer aimed at going after up to 2.5% of its outstanding common shares. This offer is designed to provide shareholders an opportunity to sell...

Continue Reading
Experience the Winter Wheat Wonderland Pop-Up by Maker's Mark

Updated Category News Views 223

Immerse Yourself in Maker's Mark's Winter Wheat Wonderland Get ready to experience something truly unique this holiday season as Maker's Mark unveils its enchanting pop-up event, the Winter Wheat Wonderland. This special event will take the vibrant spirit of Kentucky bourbon to the heart of New York City, creating a magical atmosphere for all attendees. Details of the...

Continue Reading
Innovative Muscle Composition Study Enhances Liver Transplant Care

Updated Category News Views 202

Assessment of Muscle Composition in Liver Transplant Candidates In a groundbreaking study, the utilization of AMRA Profiler 4, an advanced body-composition analysis device, was analyzed for its effectiveness in evaluating muscle composition among liver transplant candidates suffering from end-stage liver disease (ESLD). This study aims to shed light on critical health...

Continue Reading
Hansa Biopharma's Major Milestones Anticipated in 2025

Updated Category News Views 688

Hansa Biopharma's Participation in Healthcare Conferences Hansa Biopharma AB, a pioneering biopharmaceutical company, is set to make a significant presence at the 2025 J.P. Morgan Healthcare Conference. The company is renowned for its innovative approaches in addressing rare immunological disorders and has been actively engaged in developing novel therapies. This...

Continue Reading
AI for Customer Service: The Next Big Market Leap Ahead

Updated Category News Views 137

AI for Customer Service Market Growth Overview The AI for customer service market is on a remarkable trajectory, set to expand significantly over the next few years. Current projections indicate that the market size will grow from USD 12.06 billion in the near term to an impressive USD 47.82 billion by the end of the decade, achieving a compound annual growth rate (CAGR)...

Continue Reading